Clinical Report: Patterns of Surgical Recurrence in Hidradenitis Suppurativa

Overview

This study analyzes surgical recurrence patterns in 206 cases of hidradenitis suppurativa (HS), revealing an overall recurrence rate of 18.5%. Distinct recurrence types, tunnel and abscess/inflammatory nodule (AN), were linked to specific clinical factors, highlighting the importance of tailored surgical planning.

Background

Hidradenitis suppurativa is a chronic inflammatory condition that significantly impacts patients' quality of life. Surgical intervention is crucial for managing advanced cases, yet postoperative recurrence remains a challenge. Understanding recurrence patterns is essential for improving surgical outcomes and patient management.

Data Highlights

Key Findings

• Overall recurrence rate after surgery for HS was 18.5%.
• Tunnel recurrence occurred in 8.3% of cases, linked to more severe disease and larger excisions.
• AN recurrence was observed in 10.2% of cases, associated with obesity and limited preoperative ultrasound use.
• Distinguishing between tunnel and AN recurrence types enhances evaluation of surgical outcomes.
• Preoperative ultrasound and effective inflammatory control are critical in minimizing recurrence risk.

Clinical Implications

Surgeons should consider the distinct recurrence patterns when planning surgical interventions for HS. Implementing preoperative ultrasound and managing inflammation effectively may reduce recurrence rates and improve patient outcomes.

Conclusion

This study underscores the importance of understanding surgical recurrence patterns in HS, which can inform better surgical strategies and enhance patient care.

References

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment
6. Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus | Surgery | JAMA Dermatology | JAMA Network
7. Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial | Surgery | JAMA Surgery | JAMA Network
8. European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment
9. Surgical Procedural Definitions for Hidradenitis Suppurativa Developed by Expert Delphi Consensus
10. Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa